1 Onodera T, Goseki N, Kosaki G. [Prognos- tic nutritional index in gastrointestinal sur- gery of malnourished cancer patients]. Ni- hon Geka Gakkai Zasshi. 1984 Sep;85(9): 1001–5.
2 Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Prognostic nutri- tional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg To- day. 2010 May;40(5):440–3.
3 Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postop- erative outcome in pancreatic cancer. Br J Surg. 2011 Feb;98(2):268–74.
4 Pinato DJ, North BV, Sharma R. A novel, ex- ternally validated inflammation-based prog- nostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012;106(8):1439–45.
5 Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005 Jan–Feb;20(1):38–45.
6 Kuroda D, Sawayama H, Kurashige J, Iwat- suki M, Eto T, Tokunaga R, et al. Controlling Nutritional Status (CONUT) score is a prog- nostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018 Mar; 21(2):204–12.
7 Yoshida N, Baba Y, Shigaki H, Harada K, Iwat- suki M, Kurashige J, et al. Preoperative nutri- tional assessment by controlling nutritional sta- tus (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2016 Aug;40(8):1910–7.
8 Hamaguchi Y, Kaido T, Okumura S, Ko- bayashi A, Hammad A, Tamai Y, et al. Pro- posal for new diagnostic criteria for low skel- etal muscle mass based on computed tomog- raphy imaging in Asian adults. Nutrition. 2016 Nov–Dec;32(11–12):1200–5.
9 Harada K, Suzuki S, Ishii H, Aoki T, Hiraya- ma K, Shibata Y, et al. Impact of skeletal mus- cle mass on long-term adverse cardiovascular outcomes in patients with chronic kidney dis- ease. Am J Cardiol. 2017 Apr;119(8):1275–80.
10 Okumura S, Kaido T, Hamaguchi Y, Fujimo- to Y, Masui T, Mizumoto M, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015 Jun;157(6): 1088–98.
11 Liu Y, Chen X, Wang Y, Wang F, Gong Y, Zhang J. Clinical features and prognostic fac- tors for surgical treatment of esophageal squamous cell carcinoma in elderly patients. J Buon. 2019 May–Jun;24(3):1240–4.
12 Uemura M, Imataki O, Kawachi Y, Kawakami K, Hoshijima Y, Matsuoka A, et al. Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase in- hibitor. Int J Hematol. 2016 Nov;104(5):621– 7.
13 Guo R, Yu W, Meng Y, Zhang K, Xu B, Xiao Y, et al. Correlation of ASA grade and the Charlson comorbidity index with complica- tions in patients after transurethral resection of prostate. Urology. 2016 Dec;98:120–5.
14 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: develop- ment and validation. J Chronic Dis. 1987; 40(5):373–83.
15 Fujishiro M, Yahagi N, Kakushima N, Ko- dashima S, Muraki Y, Ono S, et al. Endoscop- ic submucosal dissection of esophageal squa- mous cell neoplasms. Clin Gastroenterol Hepatol. 2006 Jun;4(6):688–94.
16 Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for su- perficial squamous esophageal neoplasia: a meta-analysis. Dig Dis Sci. 2014 Aug;59(8): 1862–9.
17 Tsujii Y, Nishida T, Nishiyama O, Yamamoto K, Kawai N, Yamaguchi S, et al. Clinical out- comes of endoscopic submucosal dissection for superficial esophageal neoplasms: a mul- ticenter retrospective cohort study. Endosco- py. 2015 Sep;47(9):775–83.
18 Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, et al. Comprehen- sive registry of esophageal cancer in Japan, 2010–2011. Esophagus. 2018 Jul;14(3):189–52.
19 Iizuka T, Kikuchi D, Hoteya S. Outcomes of endoscopic submucosal dissection for super- ficial esophageal cancer in an elderly popula- tion: a retrospective single center cohort study. Endosc Int Open. 2019 Mar; 7(3): E355–60.
20 Qi ZP, Chen T, Li B, Ren Z, Yao LQ, Shi Q, et al. Endoscopic submucosal dissection for ear- ly esophageal cancer in elderly patients with relative indications for endoscopic treatment. Endoscopy. 2018 Sep;50(9):839–45.
21 Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus. 2000;13(3):226–30.
22 Natsugoe S, Matsumoto M, Okumura H, Ish- igami S, Uenosono Y, Owaki T, et al. Multiple primary carcinomas with esophageal squa- mous cell cancer: clinicopathologic outcome. World J Surg. 2005 Jan;29(1):46–9.
23 Otowa Y, Nakamura T, Takiguchi G, Yama- moto M, Kanaji S, Imanishi T, et al. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers. Eur J Surg On- col. 2016 Mar;42(3):407–11.
24 Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, et al. Modified system- ic inflammation score is useful for risk strati- fication after radical resection of squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2019 Oct;26(13):4773–81.
25 Nakajo K, Abe S, Oda I, Ishihara R, Tanaka M, Yoshio T, et al. Impact of the Charlson Co- morbidity Index on the treatment strategy and survival in elderly patients after non-cu- rative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a mul- ticenter retrospective study. J Gastroenterol. 2019 Oct;54(10):871–80.
26 Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019 Jan;16(1):1–24.
27 Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019 Jan;16(1):25–43.
28 Yoshida T, Inoue H, Usui S, Satodate H, Fu- kami N, Kudo SE. Narrow-band imaging sys- tem with magnifying endoscopy for superfi- cial esophageal lesions. Gastrointest Endosc. 2004 Feb;59(2):288–95.
29 Oyama T, Momma K. A new classification of magnified endoscopy for superficial esopha- geal squamous cell carcinoma. Esophagus. 2011;8:247–51.
30 Iwai N, Dohi O, Naito Y, Inada Y, Fukui A, Takayama S, et al. Impact of the Charlson co- morbidity index and prognostic nutritional index on prognosis in patients with early gas- tric cancer after endoscopic submucosal dis- section. Dig Endosc. 2018 Sep;30(5):616–23.
31 Guanrei Y, Songliang Q, He H, Guizen F. Nat- ural history of early esophageal squamous carcinoma and early adenocarcinoma of the gastric cardia in the People’s Republic of Chi- na. Endoscopy. 1988 May;20(3):95–8.
32 Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician. 2017 Jan;95(1): 22–8.
33 Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980 Jan;139(1):160–7.
34 Abnet CC, Arnold M, Wei WQ. Epidemiol- ogy of esophageal squamous cell carcinoma. Gastroenterology. 2018 Jan;154(2):360–73.
35 Harada K, Ida S, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus. 2016 Aug; 29(6):627–33.